BioLineRx (BLRX) Net Equity Issued and Repurchased (2013 - 2024)
BioLineRx's Net Equity Issued and Repurchased came in at -$5,000 for the quarter ended Dec 31, 2024, compared with $398,000 a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends
For the year ended Dec 31, 2024, BioLineRx's Net Equity Issued and Repurchased was $22,000, down 99.2% from the prior year.
- Net Equity Issued and Repurchased carries a four-year compound annual growth rate of -67.5% (years ended Dec 2020 to Dec 2024).
- Going back by year, Net Equity Issued and Repurchased was $2.93 million in the year ended Dec 31, 2023, $5,000 in the year ended Dec 31, 2022 (-100.0%), $10.91 million in the year ended Dec 31, 2021 (+453.9%) and $1.97 million in the year ended Dec 31, 2020.
- The figure for the quarter ended Dec 31, 2024 represents the lowest quarterly Net Equity Issued and Repurchased since the quarter ended Jun 30, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 398,000.00 |
| Sep 30, 2023 | 2.53 Mn |
| Dec 31, 2022 | 3,000.00 |
| Jun 30, 2021 | 10.90 Mn |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 1.96 Mn |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | -7,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2013 | -14.17 Mn |
| Sep 30, 2013 | 1.43 Mn |
| Jun 30, 2013 | 1.20 Mn |
| Mar 31, 2013 | 11.54 Mn |
API Access
BioLineRx Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();